The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus
Abstract
:1. Introduction
2. Podocytes
2.1. Podocytes and the Actin Cytoskeleton
2.2. Tβ4 Expression in Podocytes
2.3. The Role of Tβ4 in Podocyte Pathophysiology
3. Macrophages
3.1. Macrophage Infiltration in Glomerular Disease
3.2. The Role of Tβ4 in Kidney Macrophage Accumulation following Glomerular Injury
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Benzing, T.; Salant, D. Insights into Glomerular Filtration and Albuminuria. N. Engl. J. Med. 2021, 384, 1437–1446. [Google Scholar] [CrossRef] [PubMed]
- Long , D.A.; Norman , J.T.; Fine, L.G. Restoring the renal microvasculature to treat chronic kidney disease. Nat. Rev. Nephrol. 2012, 8, 244–250. [Google Scholar] [CrossRef]
- Miner, J.H. Glomerular basement membrane composition and the filtration barrier. Pediatr. Nephrol. 2011, 26, 1413–1417. [Google Scholar] [CrossRef] [Green Version]
- Sachs, N.; Sonnenberg, A. Cell–matrix adhesion of podocytes in physiology and disease. Nat. Rev. Nephrol. 2013, 9, 200–210. [Google Scholar] [CrossRef]
- Welsh, G.I.; Saleem, M.A. The podocyte cytoskeleton—Key to a functioning glomerulus in health and disease. Nat. Rev. Nephrol. 2011, 8, 14–21. [Google Scholar] [CrossRef] [PubMed]
- Low, T.L.; Hu, S.K.; Goldstein, A.L. Complete amino acid sequence of bovine thymosin beta 4: A thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. USA 1981, 78, 1162–1166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sanders, M.C.; Goldstein, A.L.; Wang, Y.L. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc. Natl. Acad. Sci. USA 1992, 89, 4678–4682. [Google Scholar] [CrossRef] [Green Version]
- Fan, Y.; Gong, Y.; Ghosh, P.K.; Graham, L.M.; Fox, P.L. Spatial Coordination of Actin Polymerization and ILK–Akt2 Activity during Endothelial Cell Migration. Dev. Cell 2009, 16, 661–674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santra, M.; Zhang, Z.G.; Yang, J.; Santra, S.; Santra, S.; Chopp, M.; Morris, D.C. Thymosin β4 Up-regulation of MicroRNA-146a Promotes Oligodendrocyte Differentiation and Suppression of the Toll-like Proinflammatory Pathway. J. Biol. Chem. 2014, 289, 19508–19518. [Google Scholar] [CrossRef] [Green Version]
- Bock-Marquette, I.; Saxena, A.; White, M.D.; DiMaio, J.M.; Srivastava, D. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004, 432, 466–472. [Google Scholar] [CrossRef]
- Smart, N.; Risebro, C.A.; Melville, A.A.D.; Moses, K.; Schwartz, R.J.; Chien, K.R.; Riley, P.R. Thymosin beta 4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007, 445, 177–182. [Google Scholar] [CrossRef]
- Sosne, G.; Qiu, P.; Christopherson, P.L.; Wheater, M.K. Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway. Exp. Eye Res. 2007, 84, 663–669. [Google Scholar] [CrossRef] [Green Version]
- Conte, E.; Genovese, T.; Gili, E.; Esposito, E.; Iemmolo, M.; Fruciano, M.; Fagone, E.; Pistorio, M.P.; Crimi, N.; Cuzzocrea, S.; et al. Protective effects of thymosin β4 in a mouse model of lung fibrosis. Ann. N. Y. Acad. Sci. 2012, 1269, 69–73. [Google Scholar] [CrossRef]
- Smart, N.; Bollini, S.; Dubé, K.N.; Vieira, J.M.; Zhou, B.; Davidson, S.; Yellon, D.; Riegler, J.; Price, A.N.; Lythgoe, M.F.; et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011, 474, 640–644. [Google Scholar] [CrossRef] [Green Version]
- Morris, D.; Cui, Y.; Cheung, W.; Lu, M.; Zhang, L.; Zhang, Z.; Chopp, M. A dose–response study of thymosin β4 for the treatment of acute stroke. J. Neurol. Sci. 2014, 345, 61–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sosne, G.; Qiu, P.; Ousler, G.W.; Dunn, S.P.; Crockford, D. Thymosin β4: A potential novel dry eye therapy. Ann. N. Y. Acad. Sci. 2012, 1270, 45–50. [Google Scholar] [CrossRef]
- Conte, E.; Genovese, T.; Gili, E.; Esposito, E.; Iemmolo, M.; Fruciano, M.; Fagone, E.; Pistorio, M.P.; Crimi, N.; Cuzzocrea, S.; et al. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung. Eur. J. Clin. Investig. 2012, 43, 309–315. [Google Scholar] [CrossRef] [PubMed]
- Kurts, C.; Panzer, U.; Anders, H.-J.; Rees, A.J. The immune system and kidney disease: Basic concepts and clinical implications. Nat. Rev. Immunol. 2013, 13, 738–753. [Google Scholar] [CrossRef] [PubMed]
- Pavenstädt, H.; Kriz, W.; Kretzler, M. Cell Biology of the Glomerular Podocyte. Physiol. Rev. 2003, 83, 253–307. [Google Scholar] [CrossRef] [Green Version]
- Nagata, M.; Yamaguchi, Y.; Ito, K. Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys. Anat. Embryol. 1993, 187, 275–279. [Google Scholar] [CrossRef] [PubMed]
- Reiser, J.; Kriz, W.; Kretzler, M.; Mundel, P. The Glomerular Slit Diaphragm Is a Modified Adherens Junction. J. Am. Soc. Nephrol. 2000, 11, 1–8. [Google Scholar] [CrossRef]
- Perico, L.; Conti, S.; Benigni, A.; Remuzzi, G. Podocyte–actin dynamics in health and disease. Nat. Rev. Nephrol. 2016, 12, 692–710. [Google Scholar] [CrossRef] [PubMed]
- Suleiman, H.Y.; Roth, R.; Jain, S.; Heuser, J.E.; Shaw, A.S.; Miner, J.H. Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy. J. Clin. Investig. 2017, 2, e94137. [Google Scholar] [CrossRef] [Green Version]
- Shirato, I.; Sakai, T.; Kimura, K.; Tomino, Y.; Kriz, W. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. Am. J. Pathol. 1996, 148, 1283–1296. [Google Scholar] [PubMed]
- Korhonen, M.; Ylänne, J.; Laitinen, L.; Virtanen, I. Distribution of beta 1 and beta 3 integrins in human fetal and adult kidney. Lab. Investig. 1990, 62, 616–625. [Google Scholar] [PubMed]
- Pozzi, A.; Jarad, G.; Moeckel, G.W.; Coffa, S.; Zhang, X.; Gewin, L.; Eremina, V.; Hudson, B.G.; Borza, D.-B.; Harris, R.C.; et al. β1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev. Biol. 2008, 316, 288–301. [Google Scholar] [CrossRef] [Green Version]
- Raats, C.J.I.; Born, J.V.D.; Bakker, M.A.; Oppers-Walgreen, B.; Pisa, B.J.; Dijkman, H.B.; Assmann, K.J.; Berden, J.H. Expression of Agrin, Dystroglycan, and Utrophin in Normal Renal Tissue and in Experimental Glomerulopathies. Am. J. Pathol. 2000, 156, 1749–1765. [Google Scholar] [CrossRef] [Green Version]
- Regele, H.M.; Fillipovic, E.; Langer, B.; Poczewki, H.; Kraxberger, I.; Bittner, R.E.; Kerjaschki, D. Glomerular Expression of Dystroglycans Is Reduced in Minimal Change Nephrosis But Not in Focal Segmental Glomerulosclerosis. J. Am. Soc. Nephrol. 2000, 11, 403–412. [Google Scholar] [CrossRef]
- Vasilopoulou, E.; Kolatsi-Joannou, M.; Lindenmeyer, M.T.; White, K.E.; Robson, M.G.; Cohen, C.D.; Sebire, N.J.; Riley, P.R.; Winyard, P.J.; Long, D.A. Loss of endogenous thymosin β4 accelerates glomerular disease. Kidney Int. 2016, 90, 1056–1070. [Google Scholar] [CrossRef] [Green Version]
- Guinobert, I.; Viltard, M.; Piquemal, D.; Elalouf, J.-M.; Marti, J.; Lelièvre-Pégorier, M. Identification of Differentially Expressed Genes between Fetal and Adult Mouse Kidney: Candidate Gene in Kidney Development. Nephron Physiol. 2006, 102, p81–p91. [Google Scholar] [CrossRef]
- Brunskill, E.W.; Georgas, K.; Rumballe, B.; Little, M.H.; Potter, S.S. Defining the Molecular Character of the Developing and Adult Kidney Podocyte. PLoS ONE 2011, 6, e24640. [Google Scholar] [CrossRef] [Green Version]
- Chung, J.-J.; Goldstein, L.; Chen, Y.-J.J.; Lee, J.; Webster, J.D.; Roose-Girma, M.; Paudyal, S.C.; Modrusan, Z.; Dey, A.; Shaw, A.S. Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury. J. Am. Soc. Nephrol. 2020, 31, 2341–2354. [Google Scholar] [CrossRef] [PubMed]
- Mason, W.J.; Jafree, D.J.; Pomeranz, G.; Kolatsi-Joannou, M.; Rottner, A.K.; Pacheco, S.; Moulding, D.A.; Wolf, A.; Kupatt, C.; Peppiatt-Wildman, C.; et al. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice. Sci. Rep. 2022, 12, 12172. [Google Scholar] [CrossRef]
- Brown, C.; Mullins, L.J.; Wesencraft, K.; McConnell, G.; Beltran, M.; Henderson, N.C.; Conway, B.; Hoffmann, S.; Rider, S.; Mullins, J.J. scRNA Transcription Profile of Adult Zebrafish Podocytes Using a Novel Reporter Strain. Cell. Physiol. Biochem. 2021, 55, 35–47. [Google Scholar] [CrossRef]
- Xu, B.J.; Shyr, Y.; Liang, X.; Ma, L.-J.; Donnert, E.M.; Roberts, J.D.; Zhang, X.; Kon, V.; Brown, N.J.; Caprioli, R.M.; et al. Proteomic Patterns and Prediction of Glomerulosclerosis and Its Mechanisms. J. Am. Soc. Nephrol. 2005, 16, 2967–2975. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pippin, J.W.; Brinkkoetter, P.T.; Cormack-Aboud, F.C.; Durvasula, R.V.; Hauser, P.V.; Kowalewska, J.; Krofft, R.D.; Logar, C.M.; Marshall, C.B.; Ohse, T.; et al. Inducible rodent models of acquired podocyte diseases. Am. J. Physiol. Physiol. 2009, 296, F213–F229. [Google Scholar] [CrossRef]
- Kumar, N.; Liao, T.-D.; Romero, C.A.; Maheshwari, M.; Peterson, E.L.; Carretero, O.A. Thymosin β4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II–Induced Hypertension. Hypertension 2018, 71, 1133–1142. [Google Scholar] [CrossRef]
- Mundel, P.; Reisera, J.; Borja, A.Z.M.; Pavenstädtc, H.; Davidson, G.; Kriza, W.; Zeller, R. Rearrangements of the Cytoskeleton and Cell Contacts Induce Process Formation during Differentiation of Conditionally Immortalized Mouse Podocyte Cell Lines. Exp. Cell Res. 1997, 236, 248–258. [Google Scholar] [CrossRef] [PubMed]
- O’Brien, S.P.; Smith, M.; Ling, H.; Phillips, L.; Weber, W.; Lydon, J.; Maloney, C.; Ledbetter, S.; Arbeeny, C.; Wawersik, S. Glomerulopathy in the KK.Cg-Ay/J Mouse Reflects the Pathology of Diabetic Nephropathy. J. Diabetes Res. 2013, 2013, 498925. [Google Scholar] [CrossRef] [Green Version]
- Zhu, J.; Su, L.-P.; Zhou, Y.; Ye, L.; Lee, K.-O.; Ma, J.-H. Thymosin β4 Attenuates Early Diabetic Nephropathy in a Mouse Model of Type 2 Diabetes Mellitus. Am. J. Ther. 2015, 22, 141–146. [Google Scholar] [CrossRef]
- Mora, C.A.; Baumann, C.A.; Paino, J.E.; Goldstein, A.L.; Badamchian, M. Biodistribution of synthetic thymosin β4 in the serum, urine, and major organs of mice. Int. J. Immunopharmacol. 1997, 19, 1–8. [Google Scholar] [CrossRef]
- Artelt, N.; Siegerist, F.; Ritter, A.M.; Grisk, O.; Schlüter, R.; Endlich, K.; Endlich, N. Comparative Analysis of Podocyte Foot Process Morphology in Three Species by 3D Super-Resolution Microscopy. Front. Med. 2018, 5, 292. [Google Scholar] [CrossRef] [PubMed]
- Sever, S.; Schiffer, M. Actin dynamics at focal adhesions: A common endpoint and putative therapeutic target for proteinuric kidney diseases. Kidney Int. 2018, 93, 1298–1307. [Google Scholar] [CrossRef] [PubMed]
- Padmanabhan, K.; Grobe, H.; Cohen, J.; Soffer, A.; Mahly, A.; Adir, O.; Zaidel-Bar, R.; Luxenburg, C. Thymosin β4 is essential for adherens junction stability and epidermal planar cell polarity. Development 2020, 147, dev193425. [Google Scholar] [CrossRef]
- Papakrivopoulou, E.; Jafree, D.J.; Dean, C.H.; Long, D.A. The Biological Significance and Implications of Planar Cell Polarity for Nephrology. Front. Physiol. 2021, 12, 599529. [Google Scholar] [CrossRef]
- Papakrivopoulou, E.; Vasilopoulou, E.; Lindenmeyer, M.T.; Pacheco, S.; Brzóska, H.; Price, K.L.; Kolatsi-Joannou, M.; White, K.E.; Henderson, D.J.; Dean, C.H.; et al. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury. J. Pathol. 2018, 246, 485–496. [Google Scholar] [CrossRef] [Green Version]
- Rocque, B.L.; Babayeva, S.; Li, J.; Leung, V.; Nezvitsky, L.; Cybulsky, A.V.; Gros, P.; Torban, E. Deficiency of the Planar Cell Polarity Protein Vangl2 in Podocytes Affects Glomerular Morphogenesis and Increases Susceptibility to Injury. J. Am. Soc. Nephrol. 2015, 26, 576–586. [Google Scholar] [CrossRef] [Green Version]
- Morita, T.; Hayashi, K. G-actin sequestering protein thymosin-β4 regulates the activity of myocardin-related transcription factor. Biochem. Biophys. Res. Commun. 2013, 437, 331–335. [Google Scholar] [CrossRef] [PubMed]
- Medjkane, S.; Perez-Sanchez, C.; Gaggioli, C.; Sahai, E.; Treisman, R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat. Cell Biol. 2009, 11, 257–268. [Google Scholar] [CrossRef]
- Tsirtsaki, K.; Gkretsi, V. The focal adhesion protein Integrin-Linked Kinase (ILK) as an important player in breast cancer pathogenesis. Cell Adhes. Migr. 2020, 14, 204–213. [Google Scholar] [CrossRef]
- Kumar, N.; Nakagawa, P.; Janic, B.; Romero, C.; Worou, M.E.; Monu, S.R.; Peterson, E.L.; Shaw, J.; Valeriote, F.; Ongeri, E.M.; et al. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase. Am. J. Physiol. Physiol. 2016, 310, F1026–F1034. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cavasin, M.A.; Rhaleb, N.-E.; Yang, X.-P.; Carretero, O.A. Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP. Hypertension 2004, 43, 1140–1145. [Google Scholar] [CrossRef] [Green Version]
- Rieger, K.J.; Saez-Servent, N.; Papet, M.P.; Wdzieczak-Bakala, J.; Morgat, J.L.; Thierry, J.; Voelter, W.; Lenfant, M. Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochem. J. 1993, 296 Pt 2, 373–378. [Google Scholar] [CrossRef] [Green Version]
- Wang, W.; Jia, W.; Zhang, C. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis. Int. J. Mol. Sci. 2022, 23, 13282. [Google Scholar] [CrossRef] [PubMed]
- Vasilopoulou, E.; Riley, P.R.; Long, D. Thymosin-β4: A key modifier of renal disease. Expert Opin. Biol. Ther. 2018, 18, 185–192. [Google Scholar] [CrossRef]
- Liao, T.D.; Yang, X.P.; D’Ambrosio, M.; Zhang, Y.; Rhaleb, N.E.; Carretero, O.A. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: Council for high blood pressure research. Hypertension 2010, 55, 459–467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rhaleb, N.-E.; Pokharel, S.; Sharma, U.; Carretero, O.A. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate–salt hypertensive mice. J. Hypertens. 2011, 29, 330–338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Worou, M.E.; Liao, T.-D.; D’ambrosio, M.; Nakagawa, P.; Janic, B.; Peterson, E.L.; Rhaleb, N.-E.; Carretero, O.A. Renal Protective Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in Dahl Salt-Sensitive Rats. Hypertension 2015, 66, 816–822. [Google Scholar] [CrossRef] [Green Version]
- Liao, T.D.; Nakagawa, P.; Janic, B.; D’Ambrosio, M.; Worou, M.E.; Peterson, E.L.; Rhaleb, N.E.; Yang, X.P.; Carretero, O.A. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: Mecha-nisms of renal protection in mouse model of systemic lupus erythematosus. Am. J. Physiol. Renal Physiol. 2015, 308, F1146–F1154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nakagawa, P.; Masjoan-Juncos, J.X.; Basha, H.; Janic, B.; Worou, M.E.; Liao, T.D.; Romero, C.A.; Peterson, E.L.; Carretero, O.A. Effects of N-acetyl-seryl-aspartyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosus. Physiol. Rep. 2017, 5, e13084. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Omata, M.; Taniguchi, H.; Koya, D.; Kanasaki, K.; Sho, R.; Kato, Y.; Kojima, R.; Haneda, M.; Inomata, N. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. J. Am. Soc. Nephrol. 2006, 17, 674–685. [Google Scholar] [CrossRef] [Green Version]
- Castoldi, G.; di Gioia, C.; Bombardi, C.; Preziuso, C.; Leopizzi, M.; Maestroni, S.; Corradi, B.; Zerbini, G.; Stella, A. Renal Antifibrotic Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in Diabetic Rats. Am. J. Nephrol. 2013, 37, 65–73. [Google Scholar] [CrossRef]
- Li, J.; Liu, H.; Srivastava, S.P.; Hu, Q.; Gao, R.; Li, S.; Kitada, M.; Wu, G.; Koya, D.; Kanasaki, K. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice. Hypertension 2020, 76, 1935–1944. [Google Scholar] [CrossRef] [PubMed]
- Shibuya, K.; Kanasaki, K.; Isono, M.; Sato, H.; Omata, M.; Sugimoto, T.; Araki, S.-I.; Isshiki, K.; Kashiwagi, A.; Haneda, M.; et al. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Prevents Renal Insufficiency and Mesangial Matrix Expansion in Diabetic db/db Mice. Diabetes 2005, 54, 838–845. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hinkel, R.; Ball, H.L.; DiMaio, J.M.; Shrivastava, S.; Thatcher, J.E.; Singh, A.N.; Sun, X.; Faskerti, G.; Olson, E.N.; Kupatt, C.; et al. C-terminal variable AGES domain of Thymosin beta4: The molecule’s primary contribution in support of post-ischemic cardiac function and repair. J. Mol. Cell. Cardiol. 2015, 87, 113–125. [Google Scholar] [CrossRef]
- Sosne, G.; Qiu, P.; Goldstein, A.L.; Wheater, M. Biological activities of thymosin ß4defined by active sites in short peptide sequences. FASEB J. 2010, 24, 2144–2151. [Google Scholar] [CrossRef] [Green Version]
- Navarro-González, J.F.; Mora-Fernández, C.; De Fuentes, M.M.; García-Pérez, J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 2011, 7, 327–340. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez-Iturbe, B.; Pons, H.; Quiroz, Y.; Johnson, R.J. The Immunological Basis of Hypertension. Am. J. Hypertens. 2014, 27, 1327–1337. [Google Scholar] [CrossRef] [Green Version]
- Meng, X.-M.; Nikolic-Paterson, D.; Lan, H.Y. Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol. 2014, 10, 493–503. [Google Scholar] [CrossRef]
- Carlin, L.M.; Stamatiades, E.G.; Auffray, C.; Hanna, R.N.; Glover, L.; Vizcay-Barrena, G.; Hedrick, C.C.; Cook, H.T.; Diebold, S.; Geissmann, F. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 2013, 153, 362–375. [Google Scholar] [CrossRef] [Green Version]
- Du, Q.; Tsuboi, N.; Shi, Y.; Ito, S.; Sugiyama, Y.; Furuhashi, K.; Endo, N.; Kim, H.; Katsuno, T.; Akiyama, S.; et al. Transfusion of CD206+ M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice. Am. J. Pathol. 2016, 186, 3176–3188. [Google Scholar] [CrossRef] [Green Version]
- Kawakami, T.; Lichtnekert, J.; Thompson, L.J.; Karna, P.; Bouabe, H.; Hohl, T.M.; Heinecke, J.W.; Ziegler, S.F.; Nelson, P.J.; Duffield, J.S. Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions. J. Immunol. 2013, 191, 3358–3372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lever, J.M.; Hull, T.D.; Boddu, R.; Pepin, M.E.; Black, L.M.; Adedoyin, O.O.; Yang, Z.; Traylor, A.M.; Jiang, Y.; Li, Z.; et al. Resident macrophages reprogram toward a developmental state after acute kidney injury. JCI Insight 2019, 4, e125503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lin, S.L.; Castaño, A.P.; Nowlin, B.T.; Lupher, M.L.; Duffield, J.S. Bone Marrow Ly6C high Monocytes Are Selectively Recruited to Injured Kidney and Differentiate into Functionally Distinct Populations. J. Immunol. Am. Assoc. Immunol. 2009, 183, 6733–6743. [Google Scholar]
- Liu, F.; Dai, S.; Feng, D.; Qin, Z.; Peng, X.; Sakamuri, S.S.V.P.; Ren, M.; Huang, L.; Cheng, M.; Mohammad, K.E.; et al. Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins. Nat. Commun. 2020, 11, 2280. [Google Scholar] [CrossRef]
- Minutti, C.M.; Modak, R.V.; Macdonald, F.; Li, F.; Smyth, D.J.; Dorward, D.A.; Blair, N.; Husovsky, C.; Muir, A.; Giampazolias, E.; et al. A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation. Immunity 2019, 50, 645–654. [Google Scholar] [CrossRef] [Green Version]
- Munro, D.A.D.; Hughes, J. The Origins and Functions of Tissue-Resident Macrophages in Kidney Development. Front. Physiol. 2017, 8, 837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Puranik, A.S.; Leaf, I.A.; Jensen, M.A.; Hedayat, A.F.; Saad, A.; Kim, K.W.; Saadalla, A.M.; Woollard, J.R.; Kashyap, S.; Textor, S.C.; et al. Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidney. Sci. Rep. 2018, 8, 13948. [Google Scholar] [CrossRef] [Green Version]
- Stamatiades, E.G.; Tremblay, M.-E.; Bohm, M.; Crozet, L.; Bisht, K.; Kao, D.; Coelho, C.; Fan, X.; Yewdell, W.T.; Davidson, A.; et al. Immune Monitoring of Transendothelial Transport by Kidney-Resident Macrophages. Cell 2016, 166, 991–1003. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Duffield, J.S.; Tipping, P.G.; Kipari, T.; Cailhier, J.-F.; Clay, S.; Lang, R.; Bonventre, J.V.; Hughes, J. Conditional Ablation of Macrophages Halts Progression of Crescentic Glomerulonephritis. Am. J. Pathol. 2005, 167, 1207–1219. [Google Scholar] [CrossRef] [Green Version]
- Sung, S.J.; Ge, Y.; Dai, C.; Wang, H.; Fu, S.M.; Sharma, R.; Hahn, Y.S.; Yu, J.; Le, T.H.; Okusa, M.D.; et al. Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice. J. Immunol. 2017, 198, 2589–2601. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schiffer, L.; Bethunaickan, R.; Ramanujam, M.; Huang, W.; Schiffer, M.; Tao, H.; Madaio, M.P.; Bottinger, E.P.; Davidson, A. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J. Immunol. 2008, 180, 3613. [Google Scholar] [CrossRef] [Green Version]
- You, H.; Gao, T.; Cooper, T.K.; Reeves, W.; Awad, A.S. Macrophages directly mediate diabetic renal injury. Am. J. Physiol. Physiol. 2013, 305, F1719–F1727. [Google Scholar] [CrossRef]
- Ito, S.; Nakashima, H.; Ishikiriyama, T.; Nakashima, M.; Yamagata, A.; Imakiire, T.; Kinoshita, M.; Seki, S.; Kumagai, H.; Oshima, N. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy. Am. J. Physiol. Physiol. 2021, 321, F757–F770. [Google Scholar] [CrossRef]
- Sayyed, S.G.; Ryu, M.; Kulkarni, O.P.; Schmid, H.; Lichtnekert, J.; Grüner, S.; Green, L.; Mattei, P.; Hartmann, G.; Anders, H.-J. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int. 2011, 80, 68–78. [Google Scholar] [CrossRef] [Green Version]
- Calle, P.; Hotter, G. Macrophage Phenotype and Fibrosis in Diabetic Nephropathy. Int. J. Mol. Sci. 2020, 21, 2806. [Google Scholar] [CrossRef] [Green Version]
- Sosne, G.; Chan, C.C.; Thai, K.; Kennedy, M.; Szliter, E.A.; Hazlett, L.D.; Kleinman, H.K. Thymosin Beta 4 Promotes Corneal Wound Healing and Modulates Inflammatory Mediators in vivo. Exp. Eye Res. 2001, 72, 605–608. [Google Scholar] [CrossRef]
- Sosne, G.; Christopherson, P.L.; Barrett, R.P.; Fridman, R. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Investig. Ophthalmol. Vis. Sci. 2005, 46, 2388–2395. [Google Scholar] [CrossRef]
- Sosne, G.; Szliter, E.A.; Barrett, R.; Kernacki, K.A.; Kleinman, H.; Hazlett, L.D. Thymosin Beta 4 Promotes Corneal Wound Healing and Decreases Inflammation in Vivo Following Alkali Injury. Exp. Eye Res. 2002, 74, 293–299. [Google Scholar] [CrossRef] [PubMed]
- Renga, G.; Oikonomou, V.; Moretti, S.; Stincardini, C.; Bellet, M.M.; Pariano, M.; Bartoli, A.; Brancorsini, S.; Mosci, P.; Finocchi, A.; et al. Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease. Life Sci. Alliance 2019, 2, e201900432. [Google Scholar] [CrossRef]
- Zheng, X.Y.; Lv, Y.F.; Li, S.; Li, Q.; Zhang, Q.N.; Zhang, X.T.; Hao, Z.M. Recombinant adeno-associated virus carrying thymosin β4 suppresses experimental colitis in mice. World J. Gastroenterol. 2017, 23, 242–255. [Google Scholar] [CrossRef] [PubMed]
- Kumar, N.; Yin, C. The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases. Pharmacol. Res. 2018, 134, 268–279. [Google Scholar] [CrossRef] [PubMed]
- Vasilopoulou, E.; Winyard, P.J.; Riley, P.R.; Long, D.A. The role of thymosin-beta4 in kidney disease. Expert Opin. Biol. Ther. 2015, 15, S187–S190. [Google Scholar] [CrossRef] [Green Version]
- Qiu, P.; Wheater, M.K.; Qiu, Y.; Sosne, G. Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J. 2011, 25, 1815–1826. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Evans, M.A.; Smart, N.; Dubé, K.N.; Bollini, S.; Clark, J.E.; Evans, H.G.; Taams, L.S.; Richardson, R.; Lévesque, M.; Martin, P.; et al. Thymosin beta4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing. Nat. Commun. 2013, 4, 2081. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.B.; Kalluri, R. Mechanistic connection between inflammation and fibrosis. Kidney Int. 2010, 78, S22–S26. [Google Scholar] [CrossRef] [Green Version]
- Zuo, Y.; Chun, B.; Potthoff, S.A.; Kazi, N.; Brolin, T.J.; Orhan, D.; Yang, H.-C.; Ma, L.-J.; Kon, V.; Myöhänen, T.; et al. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis. Kidney Int. 2013, 84, 1166–1175. [Google Scholar] [CrossRef] [Green Version]
- Schnaper, H.W.; Hayashida, T.; Hubchak, S.C.; Poncelet, A.-C. TGF-β signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Physiol. 2003, 284, F243–F252. [Google Scholar] [CrossRef] [Green Version]
- Tomooka, S.; Border, W.A.; Marshall, B.C.; Noble, N.A. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 1992, 42, 1462–1469. [Google Scholar] [CrossRef] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mason, W.J.; Vasilopoulou, E. The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus. Int. J. Mol. Sci. 2023, 24, 7684. https://doi.org/10.3390/ijms24097684
Mason WJ, Vasilopoulou E. The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus. International Journal of Molecular Sciences. 2023; 24(9):7684. https://doi.org/10.3390/ijms24097684
Chicago/Turabian StyleMason, William J., and Elisavet Vasilopoulou. 2023. "The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus" International Journal of Molecular Sciences 24, no. 9: 7684. https://doi.org/10.3390/ijms24097684